Immune checkpoint inhibitors in Wilms' tumor and Neuroblastoma: What now?

Published in: Cancer reports (Hoboken, N.J.) (2021)

These results could be important to consider when designing future clinical trials of ICI treatment in pediatric patients with relapsed or refractory solid tumors.

Keyphrases

clinical trial
acute myeloid leukemia
diffuse large b cell lymphoma
multiple myeloma
hodgkin lymphoma
combination therapy
phase ii
open label